Mortality News and Research

RSS

FBN features Prescient Medical's CEO

Prescient Medical Inc. announced that CEO Patricia Scheller, appeared on FOX Business Network (FBN) to discuss the company's groundbreaking products and recent achievement of CE Mark approval for their vProtect(TM) Luminal Shield Stent System.

27 Aug 2009

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.

27 Aug 2009

Nonlethal blasts can induce enough skull flexure to generate potentially damaging loads in the brain

New research on the effects of blast waves could lead to an enhanced understanding of head injuries and improved military helmet design.

27 Aug 2009

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide.

27 Aug 2009

Asian Development Bank examines poverty, hunger in Asia

A report released by the Asian Development Bank Wednesday examines how the global economic crisis is exacerbating poverty and hunger in regions of Asia, the Associated Press/Forbes writes.

27 Aug 2009

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

A new Web site, www.DeathRiskRankings.com, developed by researchers and students at Carnegie Mellon University, allows users to query publicly available data from the United States and Europe, and compare mortality risks by gender, age, cause of death and geographic region. The Web site not only gives the risk of dying within the next year, but it also ranks the probable causes and allows for quick side-by-side comparison between groups.

26 Aug 2009

Study reveals benefits of balloon dilation to heart patients with moderately impaired renal function

People with kidney disease undergo balloon dilation treatment after myocardial infarction less frequently, and therefore have a poorer prognosis. This according to new clinical research published in the journal Circulation.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Research study concludes the difference in mortality between men and women depending on the type of ACS

A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS.

26 Aug 2009

Women face higher risk of mortality rate following acute coronary syndromes

Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS; such as heart attack or unstable angina), but this difference appears attributable to factors such as severity and type of ACS, clinical differences and angiographic severity according to a study in the August 26 issue of JAMA.

26 Aug 2009

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to a study in the August 26 issue of JAMA.

26 Aug 2009

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

A chemical compound found in unpasteurised food has been detected in unusually high levels in the red blood cells of pregnant women with the condition pre-eclampsia.

26 Aug 2009

$Rates of hip fracture decline in Canada$

Rates of hip fracture decline in Canada

Standardized rates of hip fracture have steadily declined in Canada since 1985, with a more rapid decline between 1996 and 2005 and a more marked decrease among individuals age 55 to 64 years, according to a report in the August 26 issue of JAMA.

25 Aug 2009

Venlafaxine alleviates depressive symptoms

The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to investigate whether patients with depression benefit from taking drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) drug class.

25 Aug 2009

PediaVision device to detect eye disorders in autistic children

PediaVision, a company dedicated to solving the critical problem of undiagnosed vision problems affecting thousands of children, today announced a breakthrough in the use of the PediaVision Assessment Solution for autistic children.

25 Aug 2009

Study reveals factors associated with higher mortality rate in haematological malignancy

A study of 7,689 admissions from 178 adult intensive care unit s in England, Wales and Northern Ireland has revealed the factors associated with a higher mortality rate in haematological malignancy. Researchers writing in BioMed Central's open access journal Critical Care found that certain factors have a significant impact on the risk of death.

25 Aug 2009

Study reveals that people over 60 and people with chronic diseases are most vulnerable to heat waves

People over the age of 60 are the most vulnerable to heat waves, with 82% to 92% more deaths than average occurring in this age group. Risks for heat-related illness or injury - such as heat stroke, heat exhaustion and heat cramps - are also heightened in people with obesity, heart disease, diabetes and respiratory conditions as these decrease the body's ability to adapt to temperature changes.

24 Aug 2009

Research study reveals that mortality remains high in patients with pulmonary arterial hypertension

Mortality remains high among patients with pulmonary arterial hypertension awaiting lung transplant, despite changes to the allocation system that were designed to reduce mortality and increase the equitable distribution of donor organs, according to new research out of University of California San Francisco.

24 Aug 2009

New study identifies smoking as a risk factor for active TB

Smoking is a risk factor for active tuberculosis (TB) disease, according to a new study on TB incidence in Taiwan.

24 Aug 2009

The California Chronic Care Coalition launches new website to share information on chronic conditions

The California Chronic Care Coalition (CCCC) continues to advance its work toward meaningful and responsible health care reform with the launching of its consumer website: www.chroniccareca.org. Designed to help build a healthier California, the website is aimed at the more than 16 million Californians with chronic conditions such as Asthma, Diabetes, Alzheimer’s Heart disease, Epilepsy and Multiple Sclerosis.

24 Aug 2009

Mortality News and Research

FBN features Prescient Medical's CEO

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

Nonlethal blasts can induce enough skull flexure to generate potentially damaging loads in the brain

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Asian Development Bank examines poverty, hunger in Asia

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

Study reveals benefits of balloon dilation to heart patients with moderately impaired renal function

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Research study concludes the difference in mortality between men and women depending on the type of ACS

Women face higher risk of mortality rate following acute coronary syndromes

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Study reveals high levels of ergothioneine in RBCs of women with pre-eclampsia

Rates of hip fracture decline in Canada

Venlafaxine alleviates depressive symptoms

PediaVision device to detect eye disorders in autistic children

Study reveals factors associated with higher mortality rate in haematological malignancy

Study reveals that people over 60 and people with chronic diseases are most vulnerable to heat waves

Research study reveals that mortality remains high in patients with pulmonary arterial hypertension

New study identifies smoking as a risk factor for active TB

The California Chronic Care Coalition launches new website to share information on chronic conditions

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News